James A. Schoeneck
Equibles does not estimate personal net worth.
Get an email with a short summary when Kyntra Bio, Inc. publishes a filing, an earnings call transcript or a press release.
Get KYNB alertsAbout James A. Schoeneck
James A. Schoeneck is recorded as CEO at Kyntra Bio, Inc. (KYNB). The proxy statement of Kyntra Bio, Inc. reports total compensation of $717,343 for James A. Schoeneck in fiscal 2020, including a base salary of $200,000. Disclosed compensation is on record for 3 fiscal years. Kyntra Bio, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Kyntra Bio, Inc. includes Thane Wettig (CEO and Board Member), Thomas B. Neff (CEO), Jim Schoeneck (Chairman) and 3 others.
Affiliation history
-
Current
Company network
Leadership on record at Kyntra Bio, Inc.
- Thane Wettig CEO, Board Member
- Thomas B. Neff CEO
- Jim Schoeneck Chairman
- David DeLucia CFO
- Andrew E. Singer Board Member
- Michael Kauffman, M.D., Ph.D. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Kyntra Bio, Inc. (KYNB) | Interim Chief Executive Officer | $200,000 | $717,343 |
| 2019 | Kyntra Bio, Inc. (KYNB) | Interim Chief Executive Officer | $564,103 | $5,247,964 |
| 2018 | Kyntra Bio, Inc. (KYNB) | Interim Chief Executive Officer | — | — |
Recent activity
No call appearances or filed executive changes recorded yet.